Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])

Clinical trial NCT01888471 · COMPLETED

Trial details

NCT number: NCT01888471
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Streptococcus Agalactiae

Start date: 2013-12-11
Primary completion: 2014-07-14
Enrollment: 3033

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.